Top Tweets for #ASPiRATIONstudy
@ProfDMThomas speaking at @RareCancers can Forum today
NSCLC is the poster-child for modern genomic medicine brought to patients in Australia through TOGA #ASPiRATIONstudy w @OmicoAustralia @TrialsCentre
From 1 Nov small gene panels will be funded by MBS in NSCLC patients
@Mal_Itchins @OmicoAustralia Yes important to🎺this is longer than #ASPIRATIONstudy
From 1 Nov 23 Federal govt will fund a gene panel incl. EGFR, BRAF, KRAS, MetExon14, ALK fusion, ROS1, RET & NTRK1, 2 & 3
Read https://t.co/NNvv3jP0oG
Find out more at #TOGAASM23
Register for workshop https://t.co/xLg7uhvFND
Need an option for CGP now #ASPiRATIONstudy is closed to recruitment?
@OmicoAustralia CaSP can provide through remote referral
Expected turnaround time is 8-10 weeks
Referral form https://t.co/5bwuiS966I
More info https://t.co/4uWW8qpnpC
#LCSM
A 1st for Aus & highlight of TOGA trial program, #ASPIRATIONstudy examines clinical impact of upfront comprehensive genomic profiling in newly diagnosed metastatic non-squamous NSCLC pts
Huge milestone to complete 1000 pts recruitment today!👏
@TrialsCentre @OmicoAustralia
#LCSM
Diagnosed with Stage IV lung cancer, Lou joined the #ASPiRATIONstudy
Study testing revealed Lou's EGFR Exon 20 mutation which is resistant to usual therapies
Now on targeted treatment Lou's hope is restored
Inspiring TOGA research changes lives
Donate https://t.co/HvIXfaf7ZX
Read Jonie's story and her experience on the TOGA #ASPiRATIONstudy
With your donation TOGA can undertake more research that brings immediate benefit to people living with lung cancer or mesothelioma
https://t.co/HvIXfaf7ZX
100% of donations support research
$2+ are tax-deductible
#ASPiRATIONstudy thru research has enabled patients in metro, remote & regional Aus access to comprehensive genomic profiling to identify mutations that are druggable targets & thus provide life saving treatment 4 pts w newly diagnosed Stage 4 NSCLC
@TrialsCentre
@OmicoAustralia
🥳🎉recent positive MSAC recommendation to ensure NGS available to all NSCLC patients https://t.co/w0ZJc6oIbl
In the meantime, newly diagnosed mNSCLC patients w sufficent biopsy tissue can access NGS thru #ASPiRATIONstudy Refer from anywhere in Aus https://t.co/FQzqMd0cdl
#LCSM
Prof @bensolomon1 presenting the second Keynote of the day at #ALCC2023 - we can and more importantly SHOULD be performing a broad molecular panel for patients with non-squamous NSCLC, to ensure our patients can access the best possible treatment #LCSM
How?
#ASPiRATIONstudy pts referred to substudy site
Non-ASPiRATION pts w SOC testing referred thru Garvan 4 MTB report 4 ultimate substudy site referral
Read more https://t.co/ciT0nDqPUj
ASPiRATION substudy sites https://t.co/7lFFXJRH83
Most substudies https://t.co/iHs3sLf2ZK
Read about @bensolomon1 presentation on #ASPiRATIONstudy at #COSA22
Genomic testing in lung cancer moves beyond EGFR: https://t.co/egi9NQQnX1
Another lung cancer conference session with standing room only. @bensolomon1 speaking on #ASPIRATIONstudy at #cosa22
https://t.co/k5FFuzBoAR
New #ASPiRATIONstudy data showing that remote referral for molecular testing is successfully used by many sites
The 2nd graph shows 25 patients have used referral to ASPiRATION substudies to access targeted therapies
Find out more about ASPiRATION
https://t.co/FQzqMcI2Zd
Update 'til July 22 on @TOGAANZ @OmicoAustralia @TrialsCentre #ASPiRATIONstudy
609 pts referred w 534 enrolled⬇️b/c non-consent/screen fails etc
416/534 w molecular🎯 ID'd (post MTB review)⬇️b/c non-viable sample/results in progress
👀👇red arrows! https://t.co/rxH89p0ogC
#LCSM
@TOGAANZ #ASPiRATIONstudy shows⬆️molecular mutation identification thru SoC testing but CGP identifies more esp ERBB2, RET, NRG1 fusions & superior KRAS sensitivity
Refer pt for CGP from any Aus location
https://t.co/f4M428Jnfm
@OmicoAustralia @TrialsCentre
It's been our highest recruiting month to the #ASPiRATIONstudy We need 1pt/week/site to meet our expected recruitment rate but ASPiRATION also enables all newly diagnosed Aus non-sq mNSCLC patients to access NGS. Refer to an active site or access remotely https://t.co/rxH89p0ogC
We were very pleased to offer this training to our @TOGAANZ consumer representatives today on a topical issue- Molecular testing for advanced NSCLC- covering #ASPiRATIONstudy NGS & PBAC and MSAC submissions @OmicoAustralia @TrialCentre #LCSM
Thanks @DrRobZielinski for highlighting that the remote referral in #ASPiRATIONstudy sets the benchmark and for describing the unmet need in R3 healthcare for software to trace pathology samples that have been submitted for testing #TOGAsymp
#ASPiRATIONstudy allows all newly diagnosed Aus mNSCLC patients to access molecular testing. Includes remote referral from any site in Aus. Below a patient who had a ret mutation identified thru ASPiRATION and accessed ret-specific therapy #TOGAsymp @OmicoAustralia @TrialsCentre
All welcome for consumer rep. training
-molecular (NGS) testing for metastatic NSCLC
-how #ASPiRATIONstudy provides access to testing
-an explanation of PBAC & MSAC submission pathways & how to assist with drug & test reimbursement
Contact [email protected] #LCSM
Most Popular Users
Elon Musk 
@elonmusk
240.3M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.5M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.4M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.7M followers
KATY PERRY
@katyperry
87.1M followers
Taylor Swift
@taylorswift13
80.9M followers
Lady Gaga
@ladygaga
72.5M followers
Kim Kardashian
@kimkardashian
69.5M followers
Virat Kohli
@imvkohli
69M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.6M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.7M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.2M followers